Increasing to weekly adalimumab dosing leads to improved psoriasis outcomes-A retrospective single-centre review of real-world data.

Abstract

Journal of the European Academy of Dermatology and VenereologyEarly View LETTER TO THE EDITOR Increasing to weekly adalimumab dosing leads to improved psoriasis outcomes—A retrospective single-centre review of real-world data Amaani B. Hussain, Corresponding Author Amaani B. Hussain amaani.hussain@nhs.net orcid.org/0000-0002-3304-462X Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK Translational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UK Correspondence Amaani B. Hussain, Department of Dermatology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK. Email: amaani.hussain@nhs.netSearch for more papers by this authorAlison Havelin, Alison Havelin Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this authorStephanie Ball, Stephanie Ball Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this authorSophie Weatherhead, Sophie Weatherhead orcid.org/0000-0002-8705-8867 Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this authorNick J. Reynolds, Nick J. Reynolds Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK Translational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UKSearch for more papers by this authorPhilip Hampton, Philip Hampton Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this author Amaani B. Hussain, Corresponding Author Amaani B. Hussain amaani.hussain@nhs.net orcid.org/0000-0002-3304-462X Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK Translational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UK Correspondence Amaani B. Hussain, Department of Dermatology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK. Email: amaani.hussain@nhs.netSearch for more papers by this authorAlison Havelin, Alison Havelin Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this authorStephanie Ball, Stephanie Ball Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this authorSophie Weatherhead, Sophie Weatherhead orcid.org/0000-0002-8705-8867 Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this authorNick J. Reynolds, Nick J. Reynolds Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK Translational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UKSearch for more papers by this authorPhilip Hampton, Philip Hampton Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UKSearch for more papers by this author First published: 30 September 2022 https://doi.org/10.1111/jdv.18623 Amaani B. Hussain and Alison Havelin are joint first authors. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation